← Open Payments lookup

SEUL KIM: Open Payments

NPI 1790316768 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$297 in 11 payments from 8 companies in 2025. Trend: 2023 $108 · 2024 $93 · 2025 $297

Food & beverage: $297
CompanyPaymentsAmount
Janssen Biotech, Inc.3$106
Novartis Pharmaceuticals Corporation1$32
Merck Sharp & Dohme LLC2$31
AstraZeneca Pharmaceuticals LP1$30
Bayer Healthcare Pharmaceuticals Inc.1$29
Incyte Corporation1$26
SpringWorks Therapeutics, Inc.1$25
Daiichi Sankyo Inc.1$19

Products named: TECVAYLI, KISQALI, Nubeqa, KEYTRUDA, KEYTRUDA QLEX.

Industry payments across MD — which companies pay providers there.